DE602007012443D1 - Zyklische angiotensinanaloga - Google Patents

Zyklische angiotensinanaloga

Info

Publication number
DE602007012443D1
DE602007012443D1 DE602007012443T DE602007012443T DE602007012443D1 DE 602007012443 D1 DE602007012443 D1 DE 602007012443D1 DE 602007012443 T DE602007012443 T DE 602007012443T DE 602007012443 T DE602007012443 T DE 602007012443T DE 602007012443 D1 DE602007012443 D1 DE 602007012443D1
Authority
DE
Germany
Prior art keywords
analogs
agonistic
ang
cyclised
antagonistic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007012443T
Other languages
English (en)
Inventor
Marijke Haas
Leonardus Dorothea Kluskens
Anneke Kuipers
Rick Rink
Sieger Adriaan Nelemans
Gert Nikolaas Moll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Nanosystems BV
Original Assignee
Applied Nanosystems BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems BV filed Critical Applied Nanosystems BV
Publication of DE602007012443D1 publication Critical patent/DE602007012443D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602007012443T 2006-08-08 2007-08-07 Zyklische angiotensinanaloga Active DE602007012443D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2006/000414 WO2008130217A1 (en) 2006-08-08 2006-08-08 Cyclic angiotensin analogs
PCT/NL2007/050396 WO2008018792A2 (en) 2006-08-08 2007-08-07 Cyclic angiotensin analogs

Publications (1)

Publication Number Publication Date
DE602007012443D1 true DE602007012443D1 (de) 2011-03-24

Family

ID=37809189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007012443T Active DE602007012443D1 (de) 2006-08-08 2007-08-07 Zyklische angiotensinanaloga

Country Status (10)

Country Link
US (1) US8835375B2 (de)
EP (1) EP2057184B1 (de)
CN (1) CN101573373B (de)
AT (1) ATE497969T1 (de)
AU (1) AU2007282221B2 (de)
CA (1) CA2660208C (de)
DE (1) DE602007012443D1 (de)
DK (1) DK2057184T3 (de)
NZ (1) NZ574876A (de)
WO (2) WO2008130217A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2163259B1 (de) * 2008-09-12 2012-06-13 Charité-Universitätsmedizin Berlin (Charité) Verwendung eines Ang-(1-7)-Rezeptorantagonisten bei akuter Lungenverletzung
PT2376101E (pt) * 2008-12-29 2016-02-04 Trevena Inc Efectores da beta-arrestina e composições e métodos para a sua utilização
EP2267003A1 (de) 2009-06-24 2010-12-29 Applied NanoSystems B.V. Biologisch hergestellte cyclische Affinitätsmarker
EP2455388A1 (de) * 2010-11-23 2012-05-23 LanthioPep B.V. Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
EP2578599A1 (de) * 2011-10-07 2013-04-10 LanthioPep B.V. Cyclische Analoga von GLP-1 und GLP-1-verwandten Peptiden
CN104168907A (zh) 2012-01-31 2014-11-26 特维娜有限公司 β-抑制蛋白效应器及其组合物与使用方法
WO2013119870A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease
WO2013130775A1 (en) 2012-03-01 2013-09-06 Dizerega, Gere, S. Methods for treating patients undergoing multi-cycle chemotherapy
WO2013154983A1 (en) 2012-04-09 2013-10-17 Rodgers Kathleen E Molecular markers of endothelial dysfunction in gestational diabetes
EP2849773A1 (de) 2012-05-14 2015-03-25 University of Southern California Verfahren zur begrenzung der entwicklung einer hautwunde
US8557958B1 (en) * 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
WO2014021942A1 (en) 2012-08-01 2014-02-06 University Of Southern California Methods for limiting development of neurodegeneration
JP2015529684A (ja) * 2012-09-17 2015-10-08 タリックス ファーマシューティカルズ リミテッド アンジオテンシンの経口製剤
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
CA2902619A1 (en) 2013-03-15 2014-09-25 University Of Southern California Methods for treating multiple sclerosis
EP3935944A1 (de) 2013-03-15 2022-01-12 University Of Southern California, USC Stevens Verbindungen zur behandlung von erkrankungen des bewegungsapparats
KR20160016872A (ko) * 2013-05-24 2016-02-15 타릭스 파마슈티컬스 엘티디. 마르팡 증후군 및 관련 장애의 치료에서의 안지오텐신 펩티드
CA2933601A1 (en) * 2013-12-18 2015-06-25 The George Washington University, A Congressional Chartered Not-For-Prit Corporation Angiotensin ii alone or in combination for the treatment of hypotension
EP3102223A4 (de) 2014-02-07 2017-11-29 Trevena, Inc. Kristalline und amorphe formen eines beta-arrestin-effektors
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
US10183055B2 (en) 2014-07-21 2019-01-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
US9796759B2 (en) * 2014-07-21 2017-10-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Ang-(1-7) derivative oligopeptides and methods for using and producing the same
JP2022542437A (ja) * 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ 癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028168A (en) * 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
SE9700301D0 (sv) * 1997-01-31 1997-01-31 Astra Ab New compound
CA2339330A1 (en) * 1998-08-13 2000-02-24 University Of Southern California Methods to increase blood flow to ischemic tissue
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way

Also Published As

Publication number Publication date
WO2008130217A1 (en) 2008-10-30
EP2057184A2 (de) 2009-05-13
CA2660208C (en) 2012-05-22
CN101573373B (zh) 2014-04-30
CN101573373A (zh) 2009-11-04
WO2008018792A3 (en) 2008-04-03
WO2008018792A2 (en) 2008-02-14
US8835375B2 (en) 2014-09-16
NZ574876A (en) 2011-03-31
US20100055146A1 (en) 2010-03-04
AU2007282221A1 (en) 2008-02-14
AU2007282221B2 (en) 2010-09-02
EP2057184B1 (de) 2011-02-09
CA2660208A1 (en) 2008-02-14
DK2057184T3 (da) 2011-05-02
ATE497969T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
DE602007012443D1 (de) Zyklische angiotensinanaloga
BR112012017054A2 (pt) "análogo de peptídeo de oxintomodulina, seu uso, bem como composição farmacêutica"
WO2008075371A3 (en) T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation
GT200900304A (es) "antagonistas ciclicos de peptido cxcr4"
WO2004089396A3 (en) Anti-fungal peptidomimetics
NZ707292A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
ZA201001054B (en) Peptide with reduced dimer formation
UA94221C2 (en) Lipocalin protein
BR112012011332A2 (pt) agentes direcionados para gadd45beta
AR070690A1 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf (factor de crecimiento de fibroblastos)
EP1751179A4 (de) Von kasein abgeleitete peptide und therapeutischer gebrauch davon
DE602005008996D1 (de) Radiofluorierte peptide
DE602005023247D1 (de) Bipolares elektrochirurgisches Instrument mit Gelenk
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
WO2010034718A8 (fr) Proteines recombinantes a activite hemostatique capables d'induire l'agregation plaquettaire
UA98658C2 (uk) Циклічні депсипептиди
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
IL192373A (en) Arginine cyclic peptides and their use in the treatment of fungal infections
NZ607892A (en) Tfpi inhibitors and methods of use
BR112012007563A2 (pt) peptídeos sintéticos antagonistas de miostatina
WO2008093058A3 (en) Peptides and their use
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
EP2402364A3 (de) Nonapeptide mit Antitumoraktivität
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 2057184

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE